EraCal Therapeutics Ltd.
- Home
- Companies
- EraCal Therapeutics Ltd.
- Products
- Phenotypic Drug Discovery Platform
Phenotypic Drug Discovery Platform
EraCal’s platform enables unbiased and large-scale in vivo drug discovery in zebrafish larvae. The journal Science Advances published part of EraCal’s translational proof of concept. Such phenotypic strategies are capable of identifying novel mechanisms of actions and, consequently, are a prime choice to discover first-in-class drugs.